Aurobindo Pharma has informed about clarification on news item appeared in business standard on February 27, 2019 titled ‘Lacunae in Aurobindo Pharma's Medak facility in Andhra, says FDA report’ and in Financial Express on February 28, 2019 titled ‘Lacunae in Aurobindo Pharma's facility: FDA report’.
The above information is a part of company’s filings submitted to BSE.